Cargando…
Delayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum Biomarkers
With no currently available drug treatment for spinal cord injury, there is a need for additional therapeutic candidates. We took the approach of repositioning existing pharmacological agents to serve as acute treatments for spinal cord injury and previously found imatinib to have positive effects o...
Autores principales: | Kjell, Jacob, Finn, Anja, Hao, Jingxia, Wellfelt, Katrin, Josephson, Anna, Svensson, Camilla I., Wiesenfeld-Hallin, Zsuzsanna, Eriksson, Ulf, Abrams, Mathew, Olson, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752188/ https://www.ncbi.nlm.nih.gov/pubmed/25914996 http://dx.doi.org/10.1089/neu.2014.3863 |
Ejemplares similares
-
Imatinib Enhances Functional Outcome after Spinal Cord Injury
por: Abrams, Mathew B., et al.
Publicado: (2012) -
Repositioning imatinib for spinal cord injury
por: Kjell, Jacob, et al.
Publicado: (2015) -
Spatial and Cellular Characterization of mTORC1 Activation after Spinal Cord Injury Reveals Biphasic Increase Mainly Attributed to Microglia/Macrophages
por: Kjell, Jacob, et al.
Publicado: (2014) -
Improved recovery from spinal cord injury in rats with chronic parvovirus serotype-1a infection
por: Kjell, J, et al.
Publicado: (2016) -
Spatiotemporal and Long Lasting Modulation of 11 Key Nogo Signaling Genes in Response to Strong Neuroexcitation
por: Karlsson, Tobias E., et al.
Publicado: (2017)